Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica

Page 1 of about 13 results

ea0090p256 | Thyroid | ECE2023

Non-secreting pheochromocytoma or adrenal metastasis of medullary thyroid cancer? When the differential diagnosis is difficult

Bouchenna Amira , Kablia Samia Ould

Introduction: Medullary thyroid cancer (MTC) accounts for 5-10% of thyroid cancers.25% of cases may be hereditary related to multiple endocrine neoplasia type 2 A (MEN2A) and associated with pheochromocytoma. Metastases from CMT are preferentially lymph node chains. However, other localizations are possible such as adrenal metastases which remain exceptional.Observation: We report the case of a 35-year-old patient with CMT for which he underwent thyroide...
0 shares

ea0090p802 | Thyroid | ECE2023

Graves’ disease associated with thymic hyperplasia: about a case

Bouchenna Amira , Kablia Samia Ould

Introduction: The association between Graves’ disease and thymic hyperplasia was first described in 1912. Hundreds of cases have since been described. This rare association doesn’t seem fortuitous. We report a case.Observation: A 30-year-old patient with no particular personal history who consults following the onset of dyspnea with chest tightness. A CT scan of the chest revealed thymic hyperplasia. The preoperative assessment found an hyperth...
0 shares

ea0041ep727 | Male Reproduction | ECE2016

The Etiology of Azoospermia

Kablia Samia Ould , Iabassen Malek

Introduction: Azoospermia is identified in approximately 1% of all men and in 10 to 15% of infertile males. A precise diagnosis of azoospermia and systematic evaluation of the patient to establish the disease etiology are needed to guide appropriate management options. The development of intracytoplasmic sperm injection (ICSI) as an efficient therapy for severe male factor infertility has become an appropriate treatment for the majority of male reproductive tract deficiencies....
0 shares

ea0037ep1338 | Clinical Cases–Thyroid/Other | ECE2015

Polycystic ovary syndrome in women with type 1 diabetes mellitus: about three cases

Djermane Amira , Kablia Samia Ould

Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and is frequently associated with insulin resistance and type 2 diabetes mellitus. At present, women with type 1 diabetes mellitus (T1DM) are being treated with supraphysiological doses of exogenous insulin with the aim of providing a strict metabolic control. The prevalence of PCOS in women with T1DM varies depending on the diagnostic criteria employed and on the ethnicity of the population s...
0 shares

ea0041ep697 | Female Reproduction | ECE2016

Kablia Samia Ould , Iabassen Malek , Cheikh Assya

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting 6–10% of reproductive aged women. This syndrome is associated with obesity, menstrual irregularity, infertility, hirsutism and insulin resistance. It has been reported that PCOS is frequently associated with hyperprolactinemia with ranges from 17 to 50%. So for many researchers the difficulty is to differentiate between real PCOS associated with hyperprolactinemia or hyperprolactinemia wit...
0 shares

ea0037ep206 | Reproduction, endocrine disruptors and signalling | ECE2015

PCOS and thyroid disorder

Kablia Samia Ould , Lechghem Aicha , Cheikh Assya

Background: PCOS and thyroid disorder are two of the most frequent endocrine disorder in the general population. Although, the aetiopathogenesis of thyroiditis and PCOS is completely different this two entities have many features in common (cystic ovaries in hypothyroidism and thyroid disorder in PCOS).Objective: Our objective was to assess the increased incidence of thyroid disorder in females with PCOS.Methods and materials: We c...
0 shares

ea0037ep1309 | Clinical Cases–Thyroid/Other | ECE2015

Graves' disease and pregnancy

Leghbir Imane , Kablia Samia Ould , Bensalah Meriem

Introduction: Pregnancy for women with Graves’ disease is at risk for the mother and the newborn. In fact neonatal hyperthyroidism is uncommon, often transient in the context of maternal Graves’ disease (1% of children). Immediate treatment is essential for a good prognosis, prenatal treatment improves foetal and neonatal development.Case report: We report the case of a patient, known for Graves’ disease since 2006, treated initially with ...
0 shares

ea0090ep827 | Pituitary and Neuroendocrinology | ECE2023

Resistant to treatment prolactinoma: report of two cases

Lachkhem Aicha , Yahi Abdelkader , Katia Benabdelatif , Derriche Abderrahim , Kablia Samia Ould , Staifi Ahcen , Derradji Hakim

Introduction: Prolactin-secreting tumors or prolactinomas comprise the most common pituitary tumor type, acconting of 47-66% of all pituitary tumors. These tumors can be treated with dopaminergic drugs (DA) however 10-15% of prolactinomas are DA resistant.Case 1: A 39 years old man followed for a geant agressif prolactinoma discovered following a progressive decline in visual acuity and associated with visual impairment (diplopia), the MRI of the sellar ...
0 shares

ea0090ep867 | Pituitary and Neuroendocrinology | ECE2023

Null cell adenoma: case report

Lachkhem Aicha , Yahi Abdelkader , Kablia Samia Ould , Derriche Abderrahim , Staifi Ahcen , Derradji Hakim

Introduction: Pituitary adenomas, more recently referred to as pituitary neuroendocrine tumors (PitNets) from other organs, are common neoplasms comprising 10 to 20% on intracranial tumors. Null cell adenoma is a diagnosis of exclusion that requires immunonegativity for all adenohypophyseal hormones and a lack of cell type-specific transcription factors. It represents 0,6% of all pituitary tumors. Case: A 55 years old women with a history of treated thyr...
0 shares

ea0049ep138 | Clinical case reports - Pituitary/Adrenal | ECE2017

Incidental adrenal cyst: a case report

Yamina Aribi , Meriem Bensaleh , Lila Brakni , Hassiba Khaldi , Zoubir Sellal , Kablia Samia Ould

Introduction: Cystic adrenal lesions (CAL) are a rare diseases representing 5.4–6.0% of all pathological changes affecting adrenal glands. In about one-third of the cases, lesions are detected incidentally; in the remaining two-thirds cysts lesions are symptomatic, which is typically related to their large size or rapid growth. Although CAL are usually benign, since malignancy is reported in up to 7% of all CAL. Management algorithms for CAL vary and are controversial bec...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more